Publication | Closed Access

Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes

InflammationAnti-inflammatoryAntibioticsNormal Human KeratinocytesMedicineAntibiotic AdjuvantImmunologyAntimicrobial ChemotherapyDermatologyProinflammatory CytokinesPharmacologyAntiacne QuinoloneAntimicrobial ResistanceDrug Resistance